Registration

BGR GOVERNMENT AFFAIRS for AVANIR PHARMACEUTICALS, INC.

Firm
Client
Income
—
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Provide guidance related to forthcoming Nuclear Regulatory Commission rulemaking that could impact company.

LobbyistCovered position, as disclosed
DAVID BOYER New Sp Ast Pres LA, Ast Com Leg, FDA; Sp Ast Sec HHS, Con Asst, Off of WH Liaison DoD; Con Asst, Off of Sec Lab
BRENT ALAN DEL MONTE New Leg. Dir. Rep. Bliley; Sen. Counsel House Energy & Commerce Committee
JOHN STONE New Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Ctme Health Subcommittee
ROBB WALTON New Senior Health Policy Advisor and Counsel Sen Cassidy; Advisor Rep. Cassidy; Healthcare Aide Sen. Enzi

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.